# The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression

> **NCT00517387** · PHASE3 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 64 (estimated)

## Conditions studied

- Unipolar Depression

## Interventions

- **DRUG:** Quetiapine XR

## Key facts

- **NCT ID:** NCT00517387
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2010-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517387, "The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00517387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*